IL22 and inflammatory bowel disease: Discoveries in MSC-/- mice support the emerging theory that IL-22 overproduction in colitis underlies intestinal epithelial cell stress response, and call for cautious re-evaluation on IL-22 supplementation therapy for human IBD.